These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22359378)

  • 1. Anti-TNFs for prevention of postoperative recurrence of Crohn's disease: a broken record?
    Sorrentino D
    Inflamm Bowel Dis; 2012 Sep; 18(9):1624-5; author reply 1626-7. PubMed ID: 22359378
    [No Abstract]   [Full Text] [Related]  

  • 2. Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: a 3-year prospective randomized open trial.
    Yoshida K; Fukunaga K; Ikeuchi H; Kamikozuru K; Hida N; Ohda Y; Yokoyama Y; Iimuro M; Takeda N; Kato K; Kikuyama R; Nagase K; Hori K; Nakamura S; Miwa H; Matsumoto T
    Inflamm Bowel Dis; 2012 Sep; 18(9):1617-23. PubMed ID: 22081474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infliximab for postsurgical endoscopic recurrence of Crohn's disease: no trumpets yet.
    Sorrentino D; Paviotti A
    Inflamm Bowel Dis; 2009 Oct; 15(10):1458-9. PubMed ID: 19462431
    [No Abstract]   [Full Text] [Related]  

  • 4. Strategies for the prevention of postoperative recurrence of Crohn's disease.
    Yamamoto T; Watanabe T
    Colorectal Dis; 2013 Dec; 15(12):1471-80. PubMed ID: 23809911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study.
    Armuzzi A; Felice C; Papa A; Marzo M; Pugliese D; Andrisani G; Federico F; De Vitis I; Rapaccini GL; Guidi L
    J Crohns Colitis; 2013 Dec; 7(12):e623-9. PubMed ID: 23810678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic ileocolic resection versus infliximab treatment of distal ileitis in Crohn's disease: a randomized multicenter trial (LIR!C-trial).
    Eshuis EJ; Bemelman WA; van Bodegraven AA; Sprangers MA; Bossuyt PM; van Milligen de Wit AW; Crolla RM; Cahen DL; Oostenbrug LE; Sosef MN; Voorburg AM; Davids PH; van der Woude CJ; Lange J; Mallant RC; Boom MJ; Lieverse RJ; van der Zaag ES; Houben MH; Vecht J; Pierik RE; van Ditzhuijsen TJ; Prins HA; Marsman WA; Stockmann HB; Brink MA; Consten EC; van der Werf SD; Marinelli AW; Jansen JM; Gerhards MF; Bolwerk CJ; Stassen LP; Spanier BW; Bilgen EJ; van Berkel AM; Cense HA; van Heukelem HA; van de Laar A; Slot WB; Eijsbouts QA; van Ooteghem NA; van Wagensveld B; van den Brande JM; van Geloven AA; Bruin KF; Maring JK; Oldenburg B; van Hillegersberg R; de Jong DJ; Bleichrodt R; van der Peet DL; Dekkers PE; Goei TH; Stokkers PC
    BMC Surg; 2008 Aug; 8():15. PubMed ID: 18721465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience.
    Magro F; Santos-Antunes J; Vilas-Boas F; Rodrigues-Pinto E; Coelho R; Ribeiro OS; Lopes S; Macedo G
    J Crohns Colitis; 2014 Jul; 8(7):617-25. PubMed ID: 24332869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare case of free bowel perforation associated with infliximab treatment for stricturing Crohn's disease.
    Lim CS; Moon W; Park SJ; Park MI; Kim HH; Kim JB; Choi JM; Chang HK; Lee SH
    Korean J Gastroenterol; 2013 Sep; 62(3):169-73. PubMed ID: 24077628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab prevents Crohn's disease recurrence after ileal resection.
    Regueiro M; Schraut W; Baidoo L; Kip KE; Sepulveda AR; Pesci M; Harrison J; Plevy SE
    Gastroenterology; 2009 Feb; 136(2):441-50.e1; quiz 716. PubMed ID: 19109962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study.
    Yamamoto T; Umegae S; Matsumoto K
    Inflamm Bowel Dis; 2009 Oct; 15(10):1460-6. PubMed ID: 19266566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Postoperative recurrence in Crohn's disease. Risk factors and methods of prevention].
    Karoui S; Kallel L; Boubaker J; Filali A
    Tunis Med; 2006 Oct; 84(10):595-8. PubMed ID: 17193847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection.
    Regueiro M; Feagan BG; Zou B; Johanns J; Blank MA; Chevrier M; Plevy S; Popp J; Cornillie FJ; Lukas M; Danese S; Gionchetti P; Hanauer SB; Reinisch W; Sandborn WJ; Sorrentino D; Rutgeerts P;
    Gastroenterology; 2016 Jun; 150(7):1568-1578. PubMed ID: 26946343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study.
    Papamichael K; Archavlis E; Lariou C; Mantzaris GJ
    J Crohns Colitis; 2012 Oct; 6(9):924-31. PubMed ID: 22424843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crohn's disease and hidradenitis suppurativa. An uncommon association that responds to infliximab.
    Blazquez I; Gonzalez-Lama Y; Roustan G
    J Crohns Colitis; 2013 Dec; 7(12):e717-8. PubMed ID: 24080248
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of postoperative recurrence of Crohn's disease.
    van Loo ES; Dijkstra G; Ploeg RJ; Nieuwenhuijs VB
    J Crohns Colitis; 2012 Jul; 6(6):637-46. PubMed ID: 22398096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of Crohn's disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial.
    McLeod RS; Wolff BG; Ross S; Parkes R; McKenzie M;
    Dis Colon Rectum; 2009 May; 52(5):919-27. PubMed ID: 19502857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of preoperative use of infliximab on postoperative complications in patients with Crohn's disease.
    Shiraki M; Yamamoto T
    J Crohns Colitis; 2012 Dec; 6(10):1038. PubMed ID: 22763363
    [No Abstract]   [Full Text] [Related]  

  • 18. Stopping anti-TNF agents in patients with Crohn's disease in remission: is it a feasible long-term strategy?
    Sorrentino D; Nash P; Viladomiu M; Hontecillas R; Bassaganya-Riera J
    Inflamm Bowel Dis; 2014 Apr; 20(4):757-66. PubMed ID: 24572206
    [No Abstract]   [Full Text] [Related]  

  • 19. Trends in Pharmacologic Interventions for Preventing Recurrence of Crohn's Disease After Ileocolonic Surgery.
    Ong MS; Grand RJ; Mandl KD
    Inflamm Bowel Dis; 2016 Oct; 22(10):2432-41. PubMed ID: 27631599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penile Crohn's disease resolved by infliximab.
    Lee Y; Lee YM; Kim MJ; Choe YH
    J Crohns Colitis; 2013 May; 7(4):e146-9. PubMed ID: 22841132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.